TrialBlood cancer journal2021

A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.

Kalyan Nadiminti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.